Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPEDENT
2024-514196-17-00Phase 2Authorised
- Sponsor
- Ospedale Pediatrico Bambino Gesù
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of alpelisib in Dent disease type 2 (DD2), sponsored by Ospedale Pediatrico Bambino Gesù. Planned start Jan 2025; status: authorised.
02
Drugs
alpelisib
03
Conditions
Dent disease type 2 (DD2)
Beyond the preview
Go deeper on 2024-514196-17-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514196-17-00.